Related Experiment Video
Updated: Sep 8, 2025
07:15
Robust Ligature-Induced Model of Murine Periodontitis for the Evaluation of Oral Neutrophils
Published on: January 21, 2020
11.6K
Proteome-Guided Drug Target Discovery for Periodontitis.
Zoheir Alayash1, Sebastian-Edgar Baumeister1, Birte Holtfreter2
1Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany.
Journal of Clinical Periodontology
|September 6, 2025
Summary
Researchers identified three key proteins causally linked to periodontitis: fibroblast growth factor 2 (FGF2), zinc-alpha-2-glycoprotein (AZGP1), and betacellulin (BTC). These findings offer potential new therapeutic targets for treating this chronic inflammatory gum disease.
Area of Science:
- Genetics and Proteomics
- Immunology and Inflammation
- Periodontal Disease Research
Background:
- Periodontitis is a chronic inflammatory condition linked to immune system dysfunction and microbial imbalances.
- Identifying specific, druggable protein targets is crucial for developing effective periodontitis treatments.
Purpose of the Study:
- To pinpoint circulating proteins with a causal link to periodontitis.
- To assess the biological relevance and therapeutic potential of identified proteins.
Main Methods:
- Integrated proteomic data with genome-wide association studies (GWAS) for periodontitis.
- Utilized large-scale genetic datasets (Million Veteran Program, GLIDE consortium) for robust association analysis.
- Validated causal links using genetic and statistical methodologies and assessed druggability via target databases.
Main Results:
- Identified fibroblast growth factor 2 (FGF2), zinc-alpha-2-glycoprotein (AZGP1), and betacellulin (BTC) as causally associated with periodontitis.
- Replication analysis confirmed associations for 18 proteins, with 16 showing significant colocalization.
- Discovered indirect therapeutic links between identified proteins and existing anti-inflammatory drugs.
Conclusions:
- FGF2, AZGP1, and BTC are confirmed as circulating proteins causally linked to periodontitis.
- These proteins represent promising novel therapeutic targets for periodontitis.
- The study lays the groundwork for developing targeted therapies to manage periodontitis effectively.
Related Concept Videos
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:28Gene Regulation in Microbial Communities: Quorum Sensing
92
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
92